Table 3.
Characteristic | No. of Controlsb (n = 17,602) | Mammography-Detected Breast Cancer |
Woman/Clinician-Detected Breast Cancer |
P Valuec | ||||
---|---|---|---|---|---|---|---|---|
No. of Casesb (n = 8,372) | OR | 95% CI | No. of Casesb (n = 7,276) | OR | 95% CI | |||
First-degree family history of breast cancer | ||||||||
No | 15,130 | 6,474 | 1 | Referent | 5,769 | 1 | Referent | |
Yes | 2,472 | 1,898 | 1.57 | 1.47, 1.69 | 1,507 | 1.67 | 1.55, 1.80 | 0.16 |
Age at menarche, years | ||||||||
<12 | 3,384 | 1,844 | 1 | Referent | 1,435 | 1 | Referent | |
12 | 4,330 | 2,168 | 0.93 | 0.86, 1.01 | 1,856 | 0.97 | 0.89, 1.06 | 0.38 |
13 | 4,815 | 2,277 | 0.88 | 0.81, 0.95 | 1,982 | 0.92 | 0.84, 1.00 | 0.38 |
≥14 | 5,074 | 2,082 | 0.79 | 0.73, 0.86 | 2,003 | 0.85 | 0.78, 0.93 | 0.12 |
Age at first birthd, years | ||||||||
<20 | 3,082 | 1,118 | 1 | Referent | 1,100 | 1 | Referent | |
20–24 | 7,698 | 3,483 | 1.18 | 1.09, 1.29 | 2,866 | 1.03 | 0.95, 1.12 | 0.01 |
25–29 | 3,504 | 1,849 | 1.39 | 1.26, 1.53 | 1,544 | 1.13 | 1.02, 1.25 | 0.001 |
≥30 | 1,378 | 833 | 1.62 | 1.43, 1.84 | 779 | 1.32 | 1.16, 1.49 | 0.01 |
Parity | ||||||||
0 | 1,941 | 1,088 | 1 | Referent | 987 | 1 | Referent | |
1 | 1,670 | 862 | 0.69 | 0.60, 0.79 | 845 | 0.88 | 0.76, 1.01 | 0.01 |
2 | 4,852 | 2,452 | 0.68 | 0.60, 0.76 | 2,199 | 0.82 | 0.73, 0.93 | 0.01 |
≥3 | 9,139 | 3,970 | 0.59 | 0.53, 0.66 | 3,244 | 0.70 | 0.63, 0.78 | 0.01 |
Age at menopausee, years | ||||||||
<45 | 3,576 | 1,412 | 1 | Referent | 1,109 | 1 | Referent | |
45–49 | 3,283 | 1,643 | 1.23 | 1.10, 1.37 | 1,255 | 1.22 | 1.10, 1.35 | 0.92 |
50–54 | 4,536 | 2,521 | 1.31 | 1.19, 1.43 | 1,934 | 1.39 | 1.26, 1.53 | 0.30 |
≥55 | 1,686 | 997 | 1.32 | 1.18, 1.48 | 676 | 1.31 | 1.16, 1.49 | 0.94 |
Postmenopausal hormone usef | ||||||||
Never use | 3,063 | 1,154 | 1 | Referent | 1,176 | 1 | Referent | |
Estrogen only | 1,293 | 521 | 0.89 | 0.78, 1.01 | 506 | 1.23 | 1.08, 1.40 | <0.0001 |
Estrogen plus progestin only | 845 | 497 | 1.14 | 0.99, 1.31 | 422 | 1.49 | 1.29, 1.72 | 0.002 |
Other | 360 | 186 | 1.02 | 0.84, 1.25 | 154 | 1.23 | 1.00, 1.52 | 0.13 |
Alcohol consumption, drinks/ week | ||||||||
0 | 3,685 | 1,600 | 1 | Referent | 1,482 | 1 | Referent | |
0.1–6.9 | 11,620 | 5,530 | 1.06 | 0.99, 1.14 | 4,727 | 0.99 | 0.92, 1.07 | 0.12 |
≥7 | 2,296 | 1,242 | 1.24 | 1.13, 1.37 | 1,067 | 1.14 | 1.03, 1.25 | 0.14 |
Postmenopausal BMIg,h | ||||||||
<18.5 | 151 | 30 | 0.61 | 0.40, 0.92 | 68 | 1.05 | 0.77, 1.44 | 0.02 |
18.5–24.9 | 3,063 | 1,154 | 1 | Referent | 1,176 | 1 | Referent | |
25.0–29.9 | 2,637 | 1,278 | 1.31 | 1.18, 1.45 | 914 | 0.91 | 0.82, 1.01 | <0.0001 |
≥30.0 | 1,736 | 1,058 | 1.72 | 1.54, 1.92 | 732 | 1.13 | 1.01, 1.27 | <0.0001 |
Premenopausal BMIi | ||||||||
<18.5 | 62 | 6 | 0.29 | 0.12, 0.67 | 42 | 1.08 | 0.72, 1.63 | 0.003 |
18.5–24.9 | 2,197 | 811 | 1 | Referent | 1,283 | 1 | Referent | |
25.0–29.9 | 1,280 | 558 | 1.19 | 1.04, 1.37 | 621 | 0.82 | 0.72, 0.92 | <0.0001 |
≥30.0 | 983 | 424 | 1.21 | 1.04, 1.40 | 356 | 0.61 | 0.52, 0.71 | <0.0001 |
Abbreviations: BMI, body mass index; CI, confidence interval; OR, odds ratio.
a ORs were mutually adjusted for all other risk factors in the table, in addition to age, state of residence, year of diagnosis, menopausal status, educational level, history of mammography utilization, and interaction terms for interactions between BMI, postmenopausal hormone use, and menopausal status.
b Average value from 5 imputed data sets.
c Test for difference in the risk factor association by method of detection.
d Among parous women only.
e Among postmenopausal women only.
f Among normal-weight postmenopausal women.
g Weight (kg)/height (m)2.
h Among postmenopausal women who had never used postmenopausal hormones.
i Among premenopausal women only.